Monlumax
Molnupiravir INN ANTIVIRAL INDICATION Molnupiravir is indicated for the treatment of mild to moderate coronavirus disease 2019 (COVID-19) in adults with a positive SARS-COV-2 diagnostic test and who have at least one risk factor for developing severe illness. DOSAGE AND ADMINISTRATION Route of administration: OralThe recommended dose of molnupiravir is 800 mg (four 200 mg […]